We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AVR

Price
4.07
Stock movement up
+0.01 (0.25%)
Company name
Anteris Technologies Global Corp. Common Stock
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
146.27M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-08-27

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

AVR does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.07
Daily high4.33
Daily low4.04
Daily Volume891K
All-time high8.65
1y analyst estimate16.50
Beta0.74
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date6 Nov 2025

Downside potential

Loading...
Downside potential data
AVRS&P500
Current price drop from All-time high-52.98%-3.04%
Highest price drop-71.46%-56.47%
Date of highest drop11 Apr 20259 Mar 2009
Avg drop from high-28.82%-11.04%
Avg time to new high7 days12 days
Max time to new high86 days1805 days
COMPANY DETAILS
AVR (Anteris Technologies Global Corp. Common Stock) company logo
Marketcap
146.27M
Marketcap category
Small-cap
Description
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Employees
136
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner